menu

Advancing ACNE Care: Applying Current Knowledge of Patient Needs and Emerging Evidence to Improve Outcomes

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Advancing ACNE Care: Applying Current Knowledge of Patient Needs and Emerging Evidence to Improve Outcomes

close
0.25 credits
15 minutes
ReachMD Healthcare Image
Restart
Resume
Read full article
Choose a format
Get your free creditsSkip straight to the post-test if you have already participated in this activity
Media formats available:
0.25 credits
A pre-test is required to view this content.
A pre-survey is required to view this content.
Details
Presenters
Comments
  • Overview

    Depression, anxiety, failure to thrive, unemployment, low self-esteem, and suicidal ideation. What could possibly be contributing to all of these consequences? The culprit is acne—didn’t expect that, did you? Hear from dermatologists Dr. Andrew Alexis and Dr. Linda Stein Gold as they discuss the proper assessment of acne, its location—particularly beyond the face—and the differences to keep in mind when assessing skin of color. Faculty also examine the role that selective retinoid therapies play in treating acne and preventing the development of both the physical and psychological scars associated with this condition.

  • Disclosure of Conflicts of Interest

    In accordance with the ACCME Standards for Commercial Support, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. GLC resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

    Faculty:
    Andrew Alexis, MD, MPH
    Professor and Chair, Department of Dermatology
    Icahn School of Medicine at Mount Sinai
    Director, Skin of Color Center
    New York, NY

    Royalty: Springer, Wiley-Blackwell, Wolters Kluwer (UpToDate)
    Consulting Fees: Abbvie, Allergan, Arcutis, Bausch Health, Beiersdorf, Bristol Myers Squibb, Cassiopea,  Celgene, Dermavant, Foamix, Galderma, Janssen, L’Oréal, Leo, Menlo, Novartis, Pfizer, Sanofi-Regeneron, Scientis, UCB, Unilever, Valeant (Bausch Health)
    Contracted Research: Almirall, Bristol Myers Squibb, Cara, Celgene, Galderma, Leo, Menlo, Novartis, Valeant (Bausch Health)

    Linda Stein Gold, MD
    Director of Clinical Research
    Henry Ford Health System
    Department of Dermatology
    Detroit, MI

    Consulting Fees, Speaker Bureau, & Contracted Research: Almirall, Foamix, Galderma, Ortho, Sol-Gel, SUN

    Reviewers/Content Planners/Authors:

    • Stephen Chavez has nothing to disclose.
    • Sue Grossman has nothing to disclose.
    • Brian T. McDonough, MD, FAAFP, has nothing to disclose.
    • William A. Mencia, MD, FACEHP, CHCP, has nothing to disclose.
    • Colleen Resnick has nothing to disclose.
  • Learning Objectives

    After participating in this educational activity, participants should be better able to:

    • Describe the burden of acne and how it applies to personalized goal setting and treatment decisions
    • Describe guideline recommendations for classifying acne severity and determining treatment approaches for each category
    • Explain how individualized topical retinoid selection can contribute to improvements in acne severity and prevention of sequelae.
  • Target Audience

    This activity is designed to meet the educational needs of dermatologists, primary care physicians,  pediatricians, and those nurse practitioners and physician assistants.

  • Accreditation and Credit Designation Statements

    Global Learning Collaborative is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    Global Learning Collaborative designates this enduring material for a maximum of .25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Provider

    ReachMD Healthcare Image

    Prova Education, designs and executes continuing education founded on evidence-based medicine, clinical need, gap analysis, learner feedback, and more. Our mission is to serve as an inventive and relevant resource for clinical content and educational interventions across a broad spectrum of specialties. 

    Prova Education's methodology demonstrates a commitment to continuing medical education and the innovative assessment of its effects. Our goal is clear—to develop and deliver the very best education in the most impactful manner and to verify its results with progressive outcomes research. 

  • Commercial Support

    This activity is supported by an independent educational grant from Galderma.

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of GLC and Prova Education. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of Prova Education you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.

    Reproduction Prohibited

    Reproduction of this material is not permitted without written permission from the copyright owner.

  • System Requirements

    Our site requires a computer, tablet, or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/Cable/Fibre). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Chrome, Safari, Firefox, or Microsoft Edge.

  • Publication Dates

    Release Date:

    Expiration Date:

Facebook Comments

Recommended
Details
Presenters
Comments
  • Overview

    Depression, anxiety, failure to thrive, unemployment, low self-esteem, and suicidal ideation. What could possibly be contributing to all of these consequences? The culprit is acne—didn’t expect that, did you? Hear from dermatologists Dr. Andrew Alexis and Dr. Linda Stein Gold as they discuss the proper assessment of acne, its location—particularly beyond the face—and the differences to keep in mind when assessing skin of color. Faculty also examine the role that selective retinoid therapies play in treating acne and preventing the development of both the physical and psychological scars associated with this condition.

  • Disclosure of Conflicts of Interest

    In accordance with the ACCME Standards for Commercial Support, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. GLC resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

    Faculty:
    Andrew Alexis, MD, MPH
    Professor and Chair, Department of Dermatology
    Icahn School of Medicine at Mount Sinai
    Director, Skin of Color Center
    New York, NY

    Royalty: Springer, Wiley-Blackwell, Wolters Kluwer (UpToDate)
    Consulting Fees: Abbvie, Allergan, Arcutis, Bausch Health, Beiersdorf, Bristol Myers Squibb, Cassiopea,  Celgene, Dermavant, Foamix, Galderma, Janssen, L’Oréal, Leo, Menlo, Novartis, Pfizer, Sanofi-Regeneron, Scientis, UCB, Unilever, Valeant (Bausch Health)
    Contracted Research: Almirall, Bristol Myers Squibb, Cara, Celgene, Galderma, Leo, Menlo, Novartis, Valeant (Bausch Health)

    Linda Stein Gold, MD
    Director of Clinical Research
    Henry Ford Health System
    Department of Dermatology
    Detroit, MI

    Consulting Fees, Speaker Bureau, & Contracted Research: Almirall, Foamix, Galderma, Ortho, Sol-Gel, SUN

    Reviewers/Content Planners/Authors:

    • Stephen Chavez has nothing to disclose.
    • Sue Grossman has nothing to disclose.
    • Brian T. McDonough, MD, FAAFP, has nothing to disclose.
    • William A. Mencia, MD, FACEHP, CHCP, has nothing to disclose.
    • Colleen Resnick has nothing to disclose.
  • Learning Objectives

    After participating in this educational activity, participants should be better able to:

    • Describe the burden of acne and how it applies to personalized goal setting and treatment decisions
    • Describe guideline recommendations for classifying acne severity and determining treatment approaches for each category
    • Explain how individualized topical retinoid selection can contribute to improvements in acne severity and prevention of sequelae.
  • Target Audience

    This activity is designed to meet the educational needs of dermatologists, primary care physicians,  pediatricians, and those nurse practitioners and physician assistants.

  • Accreditation and Credit Designation Statements

    Global Learning Collaborative is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    Global Learning Collaborative designates this enduring material for a maximum of .25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Provider

    ReachMD Healthcare Image

    Prova Education, designs and executes continuing education founded on evidence-based medicine, clinical need, gap analysis, learner feedback, and more. Our mission is to serve as an inventive and relevant resource for clinical content and educational interventions across a broad spectrum of specialties. 

    Prova Education's methodology demonstrates a commitment to continuing medical education and the innovative assessment of its effects. Our goal is clear—to develop and deliver the very best education in the most impactful manner and to verify its results with progressive outcomes research. 

  • Commercial Support

    This activity is supported by an independent educational grant from Galderma.

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of GLC and Prova Education. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of Prova Education you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.

    Reproduction Prohibited

    Reproduction of this material is not permitted without written permission from the copyright owner.

  • System Requirements

    Our site requires a computer, tablet, or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/Cable/Fibre). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Chrome, Safari, Firefox, or Microsoft Edge.

  • Publication Dates

    Release Date:

    Expiration Date:

Facebook Comments

Schedule16 Oct 2021